CEO Strategic
Message
At EUDA Health Holdings, we are building a leading platform in non-invasive and preventive healthcare with a clear focus on longevity. Across Southeast Asia and China, where over 1.8 billion people face rapid aging, we aim to deliver innovative and science backed solutions that are both accessible and scalable. Recent milestones include the launch of T-cell immunotherapies, the introduction of Euda Helixé, our next generation gene modulating supplement, and a Letter of Intent to acquire GO POSB, giving us access to advanced iPSC technology. At the same time, our Bioenergy Capsules are expanding across Singapore, Malaysia, and China, providing a wellness entry point into our broader ecosystem.
Looking ahead, EUDA is shaping Asia’s hub for longevity and regenerative health. By combining stem cell and immunotherapy pipelines with proprietary consumer health technologies, we are creating a vertically integrated model that spans everyday wellness to hospital grade treatments. This approach strengthens our market position, diversifies revenue, and drives long term value for shareholders as we lead the shift from reactive treatment to proactive longevity focused care. As part of this vision, we are preparing to expand into India, the Middle East, Indonesia, and Vietnam, markets that represent both significant demographic opportunity and rising demand for advanced wellness and regenerative therapies.
